CF Foundation invests up to $2M in Nanite's gene therapy delivery method | $2M investment may lead to safer, efficient delivery of gene therapies
The CF Foundation is investing up to $2 million in Nanite to develop non-viral methods of gene therapy delivery for cystic fibrosis.